Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual-chamber pacemaker.

Abstract

BackgroundElderly patients having a permanent pacemaker frequently have atrial remodeling. We examined the association between routine biomarkers and atrial fibrillation (AF) in patients receiving a dual‐chamber pacemaker for sinus node disease (SND) or second‐/third‐degree atrioventricular block.MethodsWe recorded clinical, laboratory, and electrocardiographic parameters as well as pacemaker lead parameters at implantation. The final analysis included 217 patients with SND and 393 patients with atrioventricular block. Notably, 102/217 (47%) of the SND patients (median age: 77 years, 54% men) and 54/393 (14%) of the atrioventricular block patients (median age: 79 years, 54% men) had AF history (paroxysmal or persistent).ResultsMultivariable analysis showed that red blood cell distribution width (RDW) (OR: 1.17; 95% CI: 1.05‐1.36; P = .05) and serum γ‐glutamyl transferase (γGT) levels (OR: 1.15; 95% CI: 1.03‐1.28; P = .04) were independently associated with AF history in patients with SND. In ROC curve analysis, the area under the curve (AUC) was 0.648; P < .01 for RDW, and 0.753; P < .01 for γGT. A RDW cut‐off point of 14 was associated with AF with a sensitivity of 67% and a specificity of 68%, while a γGT cut‐off point of 21 was associated with AF with a sensitivity of 80% and a specificity of 65%. In patients with second‐/third‐degree atrioventricular block, there were no significant independent correlations between AF and the parameters studied.ConclusionsIn elderly patients with SND, RDW and γGT have an independent association with AF history. Our study failed to show any corresponding associations in patients with advanced disorders of atrioventricular conduction.